Abstract
AbstractAs a measure of cytotoxic potency, half-maximal inhibitory concentration (IC50) is the concentration at which a drug exerts half of its maximal inhibitory effect against target cells. It can be determined by various methods that require applying additional reagents or lysing the cells. Here, we describe a label-free Sobel-edge-based method, which we name SIC50, for the evaluation of IC50. SIC50 classifies pre-processed phase-contrast images with a state-of-art vision transformer and allows for the continuous assessment of IC50 in a faster and more cost-efficient manner. We have validated this method using four drugs and 1536-well plates, as well as built a first-of-its-kind web application. We anticipate this method will assist in the high-throughput screening of chemical libraries (e.g., small molecule drugs, siRNA, and microRNA and drug discovery.
Publisher
Cold Spring Harbor Laboratory
Reference31 articles.
1. The American Cancer Society medical and editorial content team. Lifetime risk of developing or dying from cancer. Cancer.org. (2022).
2. IQVIA institute report. Global Oncology Trends 2022 Outlook to 2026 (2022).
3. Research and development spending to bring a single cancer drug to market and revenues after approval;JAMA Intern Med,2017
4. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
5. Exocytosis of MTT formazan could exacerbate cell injury;L, L;Toxicol in Vitro,2012